Achieving Success in the Rare Disease Space

Published on: 

Lessons learned around commercializing new products in this niche sector

Andy Udell, North American president at Calliditas Therapeutics, a specialty pharma company, uncovers the complexities surrounding rare disease product commercialization, while also shedding light on outreach strategies that help spread awareness of new medications.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.